
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 396091-73-9 | 货号 | BCP28075 |
中文名 | 帕西瑞肽 | ||
英文名 | Pasireotide | ||
中文别名 | |||
英文别名 | SOM 230; SOM-230; SOM230; | ||
SMILES | C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN | ||
化学名称 | |||
分子式 | C58H66N10O9 | 分子量 | 1047.23 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs. |
Tags:Pasireotide 供应商,Pasireotide 购买,Pasireotide 生产,Pasireotide 批量,Pasireotide 供应,Pasireotide 订购,Pasireotide 采购